|
• مرض التصلب العصبي المتعدد |
|
|
|
|
• منتدى مرض التصلب العصبي المتعدد السعودي |
|
حياكم الله في منتدى مرض التصلب العصبي المتعدد السعودي
في الأعوام القليلة الماضية أصبح مرض التصلب العصبي المُتعدد أكثر انتشارا بشكل ملحوظ. وأكثر ما يثير انزعاج المصــاب هو عدم فهمه للمرض و كذلك جهل الكثيرين به ، خــاصة أولئك القريبين من أهل وأصدقاء أو زملاء عمل!
حتى الآن لا يوجد على الشبكة الإلكترونية باللغة العربية إلا القليل من المعلومات عن هذا المرض الذي يصيب العديد منا. بينما تزدهر في اللغات الأخرى الدراســات والمعلومــات والقصص الإنسانية التي تبين تجــارب المئــات معه. هدفنا أن نكون حلقة وصل بين التجارب الإنسانية في بلادنا العربية.
هذا مكــان فضـــاء. شاركونا بناءه بأحسن ما تستطيع قدراتكم و مواهبكم و أريحيتكم من عطاء. لنا ولكم و لمستقبل أكثر تفهما وإنسانية.
اهـــلا بكـــم.
|
|
• آخر الأخبار |
| MSIF launch: What is an MS Centre? |
|
- بواسطة MSIF
|
MSIF have published What is an MS Centre in collaboration with Rehabilitation in MS (RIMS), the Consortium of MS Centers (CMSC) and the International Organization of Multiple Sclerosis Nurses (IOMSN).
للمزيد...
|
1 المشاهدات
|
| Insight Into How Brain Stem Cells Develop Into Cells Which Repair Damaged Tissue |
|
- بواسطة Medical News Today
|
The joint research, funded by the National Multiple Sclerosis Society and the UK MS Society as well as the National Institutes of Health and Howard Hughes Medical Institute, was conducted by scientists at the University of California San Francisco (UCSF) and University of Cambridge and was published in the journal Genes and Development.
...[للمزيد]
|
1 المشاهدات
|
| Cognitive deficits in multiple sclerosis patients with cerebellar symptoms |
|
- بواسطة MSIF
|
|
Some patients with MS may develop some level of cognitive dysfunction over the disease. In this study the authors found that people with MS and with symptoms suggestive of cerebellar involvement had more pronounced cognitive dysfunction in specific domains such as attention and verbal fluency than people with MS but without cerebellar symptoms. For this reason, the authors suggested that...[للمزيد]
|
1 المشاهدات
|
| Measures in the first year of therapy predict the response to interferon {beta} in MS |
|
- بواسطة MSIF
|
|
The Interferon (IFN) beta is one of the first line treatments for relapsing-remitting MS. As not all patients will have a satisfactory response to IFN beta, the development of criteria addressed to identify those patients who will have future treatment failure is essential, in order to be able to offer them other treatment options as soon as possible, to avoid the waste of a valuable time. The...[للمزيد]
|
1 المشاهدات
|
| Tysabri and PML |
|
- بواسطة MSIF
|
According to Biogen Idec, a tenth confirmed case of progressive multifocal leukoencephalopathy (PML, a viral infection of the brain that usually leads to death or severe disability) has occurred among people who have used Tysabri (natalizumab, Biogen Idec and Elan Pharmaceuticals) after it became available for prescription in July 2006.
...[للمزيد]
|
1 المشاهدات
|
|
|